Currently, CAL 18 only warns about grapefruit as a consequence of its impact on the bioavailability of sure medicines through the selective inhibition of cytochrome P450 3A4 isoenzymes. Even so the products data (PI) For brand new medicines which have been substrates for CYP3A4 more and more mention other fruits (past just grapefruit) as interactin